Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LTC004 in metastatic colorectal cancer
NCT06384235Phase 2Not yet recruiting
- Sponsor
- Leto Laboratories
- Start
- Apr 2024
- Primary completion
- Aug 2025
- Modality
- Cytokines & Interferons
01
Overview
A Phase 2 trial of LTC004 in metastatic colorectal cancer (mCRC), sponsored by Leto Laboratories. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
LTC004
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT06384235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06384235.